Pfizer is on the lookout for further acquisitions in the area of emerging markets, established products, inflammatory diseases as well as cancer and alzheimer, German daily Handelsblatt said, citing the drug maker's chief financial officer. Pfizer CFO Frank D'Amelio told Handelsblatt that the world's largest drug maker was interested in bolt-on acquisitions. On Tuesday Pfizer posted higher-than-expected quarterly results.